Patent US4039685A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4039685A Expired / Lapsed US ⏱️ 0.0 years remaining

1-phenoxy-2-hydroxy-3-tert.-butylamino propane antiarrhythmic compounds

Assignee: Boehringer Ingelheim GmbH
•
Filing: 1975-04-25
•
Granted: 1977-08-02
•
Expires: 1995-04-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A compound selected from the group consisting of racemates of 1-phenoxy-2-hydroxy-3-tert.-butylamino propanes of the formula ##STR1## wherein R is selected from the group consisting of alkynyloxy of 2 to 4 carbon atoms, and R 1 is selected from the group consisting of hydrogen, halogen and alkoxy of 1 to 4 carbon atoms, their optically active isomers and their non-toxic, pharmaceutically acceptable acid addition salts of said racemates and said optically active isomers which compounds possess bradycardia activity and isoproterenol antagonistic activity and also antiarrhythmic activity.

Inventors

  • 👤 Herbert Koppe
  • 👤 Albrecht Engelhardt
  • 👤 Karl Zeile

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 05:47
CPC Classifications
C; C07; C07D; C07D309/00; C07D309/02; C07D309/08; C07D309/10; C07D309/12; A; A61; A61K; A61K31/00; A61K31/13; A61K31/135; A61K31/14; A61K31/275; A61K31/33; A61K31/395; A61K31/495; A61K31/505

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 65 words
A compound selected from the group consisting of racemates of 1-phenoxy-2-hydroxy-3-tert.-butylamino propanes of the formula ##STR6## where R is alkynyloxy of 2 to 4 carbon atoms, R 1 is selected from the group consisting of hydrogen, halogen and alkoxy of 1 to 4 carbon atoms, their optically active isomers and their non-toxic, pharmaceutically acceptable acid addition salts of said racemates and said optically active isomers.
Claim 2
Dependent Claim 65 words
A compound selected from the group consisting of racemates of 1-phenoxy-2-hydroxy-3-tert.-butylamino propanes of the formula ##STR6## where R is alkynyloxy of 2 to 4 carbon atoms, R 1 is selected from the group consisting of hydrogen, halogen and alkoxy of 1 to 4 carbon atoms, their optically active isomers and their non-toxic, pharmaceutically acceptable acid addition salts of said racemates and said optically active isomers.
Claim 3
Dependent Claim 10 words
A compound of claim 1 wherein R 1 is hydrogen.
Claim 4
Dependent Claim 23 words
A compound of claim 1 which is selected from the group consisting of 1-(2-propargyloxyphenoxy)-2-hydroxy-3-tert.-butylamino propane and its non-toxic, pharmaceutically acceptable acid addition salts.
Claim 5
Dependent Claim 26 words
A therapeutic composition having antiarrhythmic acitivity comprising a safe and effective amount of a compound of claim 1 and a major amount of a pharmaceutical carrier.
Claim 6
Dependent Claim 24 words
A method of inducing antiarrhythmic acitivity in warm-blooded animals comprising administering to warm-blooded animals an antiarrhythmically effective amount of a compound of claim 1.
Claim 7
Dependent Claim 25 words
The method of claim 5 wherein the compound is selected from the group consisting of 1-(2-propargyloxyphenoxy)-2-hydroxy-3-tert.-butylamino propane and its non-toxic, pharmaceutically acceptable acid addition salts.

References Cited (Backward Citations)

US3501769A Cited
US3483221A Cited
US3379761A Cited
US3542874A Cited
US3872147A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-08-01 1981-01-31 1981-08-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-08-01 1985-01-31 1985-08-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-08-01 1989-01-31 1989-08-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag